Skip to main content
hello world

BriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)

AI-generated - The Globe and Mail - Thu Feb 1, 1:48AM CST

BriaCell Therapeutics Corp is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

SymbolNameTotal ReturnPeriod
GMTNGold Mountain Mining Corp-63.636364YTD
HUTHut 8 Corp-40.667421YTD
NUAGNew Pacific Metals Corp-35.458167YTD
NEXTNextSource Materials Inc-33.333333YTD
SGLDSabre Gold Mines Corp-32.142857YTD
AEGAegis Brands Inc.-29.411765YTD
NGNovagold Resources Inc-28.888889YTD
LACLithium Americas Corp-28.470588YTD
NPKVerde AgriTech Ltd-27.388535YTD
SGNLSignal Gold Inc-25.925926YTD
BCTBriaCell Therapeutics Corp-25.641026YTD
FURYFury Gold Mines Ltd-25.373134YTD
FTUUS Financial 15 Split Corp-24YTD
LAACLithium Americas (Argentina) Corp-23.712575YTD
EGLXEnthusiast Gaming Holdings Inc-23.684211YTD
FRFirst Majestic Silver Corp-23.00123YTD
SOLGSolGold PLC-22.857143YTD
COGCondor Gold PLC-22.222222YTD
GAugusta Gold Corp-21.686747YTD
APSAptose Biosciences Inc-21.492537YTD
NANONano One Materials Corp-21.161826YTD
EXROExro Technologies Inc-21.09375YTD
DSVDiscovery Silver Corp-21.052632YTD
LGDLiberty Gold Corp-20.967742YTD
EDVEndeavour Mining PLC-20.2217YTD

All data provided as of January 30, 2024.

More about BriaCell Therapeutics Corp

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics Corp is listed under BCT on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.